[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP20040917B1 - Topiäśki farmaceutski pripravci koji sadrže proantocijanide za tretman dermatitisa - Google Patents

Topiäśki farmaceutski pripravci koji sadrže proantocijanide za tretman dermatitisa

Info

Publication number
HRP20040917B1
HRP20040917B1 HRP20040917AA HRP20040917A HRP20040917B1 HR P20040917 B1 HRP20040917 B1 HR P20040917B1 HR P20040917A A HRP20040917A A HR P20040917AA HR P20040917 A HRP20040917 A HR P20040917A HR P20040917 B1 HRP20040917 B1 HR P20040917B1
Authority
HR
Croatia
Prior art keywords
dermatitis
treatment
pharmaceutical compositions
topical pharmaceutical
proanthocyanidins
Prior art date
Application number
HRP20040917AA
Other languages
English (en)
Inventor
Marco Mastrodonato
Roberto Ciattini
Original Assignee
Sinclair Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Limited filed Critical Sinclair Pharmaceuticals Limited
Publication of HRP20040917A2 publication Critical patent/HRP20040917A2/hr
Publication of HRP20040917B1 publication Critical patent/HRP20040917B1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Farmaceutski pripravci za topičko davanje koji kao aktivne sastojke sadrže proantocijanidine same ili u kombinaciji s gliciretinskom kiselinom, telmesteinom, alfa-bisabololom ili drugim komponentama koji imaju komplementarnu aktivnost u smjesi s pogodnim nosačem, a korisni su u tretmanu različitih patoloških stanja kao što je atopični dermatitis, alergijski kontaktni dermatitis, seborični dermatitis, radijacijski dermatitis, psorijaza, kseroza i atopia kao i za tretman upalnih stanja sluznice.
HRP20040917AA 2002-04-09 2004-10-05 Topiäśki farmaceutski pripravci koji sadrže proantocijanide za tretman dermatitisa HRP20040917B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000756A ITMI20020756A1 (it) 2002-04-09 2002-04-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti
PCT/EP2003/003329 WO2003084553A1 (en) 2002-04-09 2003-03-31 Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis

Publications (2)

Publication Number Publication Date
HRP20040917A2 HRP20040917A2 (en) 2005-02-28
HRP20040917B1 true HRP20040917B1 (hr) 2013-03-31

Family

ID=11449673

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20040917AA HRP20040917B1 (hr) 2002-04-09 2004-10-05 Topiäśki farmaceutski pripravci koji sadrže proantocijanide za tretman dermatitisa

Country Status (31)

Country Link
US (4) US7262180B2 (hr)
EP (1) EP1494692B1 (hr)
JP (1) JP4861606B2 (hr)
KR (1) KR101065645B1 (hr)
CN (1) CN1646151B (hr)
AR (1) AR039269A1 (hr)
AT (1) ATE361084T1 (hr)
AU (1) AU2003226754B2 (hr)
BR (2) BR0309061A (hr)
CA (1) CA2481770C (hr)
CY (1) CY1106628T1 (hr)
DE (1) DE60313597T2 (hr)
DK (1) DK1494692T3 (hr)
ES (1) ES2285158T3 (hr)
GE (1) GEP20074176B (hr)
HK (1) HK1075617A1 (hr)
HR (1) HRP20040917B1 (hr)
IL (1) IL164434A (hr)
IT (1) ITMI20020756A1 (hr)
JO (1) JO2448B1 (hr)
MX (1) MXPA04009755A (hr)
MY (1) MY137060A (hr)
NO (1) NO332753B1 (hr)
NZ (1) NZ535813A (hr)
PL (1) PL204953B1 (hr)
PT (1) PT1494692E (hr)
RU (1) RU2320362C2 (hr)
TW (1) TWI345979B (hr)
UA (1) UA81408C2 (hr)
WO (1) WO2003084553A1 (hr)
ZA (1) ZA200408100B (hr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
WO2004103321A2 (en) 2003-05-16 2004-12-02 Johnson & Johnson Consumer Companies, Inc. Topical treatment of ingrown hairs
US20050031571A1 (en) * 2003-05-16 2005-02-10 Khaiat Alain V. Topical treatment of ingrown hairs
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
ITMI20031941A1 (it) 2003-10-09 2005-04-10 Sinclair Pharmaceuticals Ltd Composizioni farmaceutiche topiche per il trattamento delle dermatiti
US20050260152A1 (en) * 2004-05-03 2005-11-24 Jaghab Khalil C Hair growth composition
JP2006022090A (ja) * 2004-06-08 2006-01-26 Ajinomoto Co Inc ピロリドンカルボン酸亜鉛塩から成る炎症抑制剤
FR2871060B1 (fr) * 2004-06-08 2008-07-11 Ajinomoto Kk Agent suppresseur pour l'inflammation et procede l'utilisant
TW200744658A (en) * 2005-10-12 2007-12-16 Pentapharm Ag Topical composition for use as a skin lightener
US7897800B2 (en) * 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US20080103103A1 (en) * 2006-10-30 2008-05-01 Bahram Memarzadeh Reagents and methods to treat ocular diseases and infection
JP5125122B2 (ja) * 2007-01-31 2013-01-23 大正製薬株式会社 アダパレン含有外用剤組成物
KR100823533B1 (ko) * 2007-02-27 2008-04-30 바이오스펙트럼 주식회사 알파 비사볼올을 유효성분으로 포함하는 피부 상태 개선용조성물
JP4990352B2 (ja) * 2007-03-01 2012-08-01 株式会社Ｔｋバイオ研究所 アレルギー疾患及び自己免疫疾患に有効な医薬
DE102007017851A1 (de) * 2007-04-16 2008-10-23 Schülke & Mayr GmbH Zusammensetzung auf Basis von Glycerinether/Polyol-Gemischen
CA2686511A1 (fr) * 2007-05-11 2008-11-20 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
US20100323983A1 (en) * 2007-05-11 2010-12-23 Marc Moutet Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof, and uses thereof
EP2155212A2 (fr) * 2007-05-11 2010-02-24 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
US20100298259A1 (en) * 2007-05-11 2010-11-25 Marc Moutet Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
CN101496772B (zh) * 2008-01-31 2013-04-24 姜宁 植物有效成分抗衰舒敏组合物
KR100823535B1 (ko) * 2008-02-20 2008-04-21 바이오스펙트럼 주식회사 알파 비사볼올을 유효성분으로 포함하는 탈모 방지 또는발모 촉진용 조성물
US20100249060A1 (en) * 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
IT1397246B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
US8372382B2 (en) * 2010-10-01 2013-02-12 Mary Kay, Inc. Skin moisturizer and age fighting formula
JP5740666B2 (ja) * 2011-02-10 2015-06-24 株式会社メニコンネクト 眼科用組成物
CN102206242A (zh) * 2011-03-28 2011-10-05 中国人民解放军军事医学科学院放射与辐射医学研究所 β体甘草酸及其衍生物在辐射防护中的用途
CA2845570A1 (en) * 2011-08-16 2013-02-21 Kate Somerville Skincare, Llc. Dermal rejuvenation compositions and methods
KR101950662B1 (ko) * 2011-09-28 2019-02-20 라이온 가부시키가이샤 구강용 조성물
ITMO20120036A1 (it) * 2012-02-15 2013-08-16 Drex Pharma S R L Composizione coadiuvante per uso topico
CN102614213A (zh) * 2012-02-23 2012-08-01 武汉华纳联合药业有限公司 甘草酸、甘草次酸或其盐的用途及其凝胶组合物和制备方法
JP5918163B2 (ja) * 2012-03-22 2016-05-18 富士フイルム株式会社 透明性の高い乳化組成物及び透明性の高い化粧料
US20150118334A1 (en) * 2012-06-17 2015-04-30 Kamedis Ltd Topical compositions for the treatment of chronic inflammatory skin disease
BR102012022291B8 (pt) * 2012-09-04 2022-03-15 Antonio Jose Trassi Processo de fabricação de produto para tratamento da psoríase
DK2705847T3 (da) * 2012-09-05 2014-10-06 Psoriasis & Creams Sweden Ab Sammensætning til behandling af psoriasis
US9861645B2 (en) * 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
CN103908458A (zh) * 2013-01-04 2014-07-09 厦门鹭佳生物科技有限公司 甘草次酸、甘草酸在制备预防或治疗放射性软组织损伤药物中的应用
CN103356438B (zh) * 2013-07-11 2014-09-10 深圳市宜丽环保科技有限公司 一种专用于女性私处的护理液
ES2662854T3 (es) * 2013-08-19 2018-04-10 Rachid Ennamany Composición dermatológica a partir de células madre vegetales y un derivado de ácido salicílico
EP2907513A1 (en) 2014-02-18 2015-08-19 Bionoox Suisse SA Compositions comprising dihydroquercetin for use in methods for alleviating the effects associated with skin inflammatory disorders
CN103830303B (zh) * 2014-03-11 2016-03-02 北京德默高科医药技术有限公司 一种预防褥疮的组合物
ES2856553T3 (es) 2015-03-18 2021-09-27 Bionoox Suisse Sa Composiciones que comprenden dihidroquercetina para uso en métodos para el tratamiento del herpes
JP6606370B2 (ja) * 2015-07-30 2019-11-13 章博 田井 抗アレルギー剤及びメディエーター遊離阻害剤
AU2016323967A1 (en) * 2015-09-17 2018-03-22 June Jacobs Laboratories, Llc Compositions and methods for the treatment and prevention of radiation dermatitis
JP6992057B2 (ja) 2016-06-10 2022-01-13 クラリティ コスメティックス インコーポレイテッド 非面皰形成性の毛髪および頭皮ケア製剤ならびにその使用方法
KR101839109B1 (ko) * 2016-09-22 2018-03-15 ㈜프론트바이오 퍼플콘 추출물을 함유하는 피부 질환의 예방 또는 치료용 약제학적 조성물
US20190321395A1 (en) * 2018-04-20 2019-10-24 Oread Therapeutics Treatment of psoriasis, seborrheic dermatitis, and eczema of the head and neck
IT201900013314A1 (it) * 2019-07-30 2021-01-30 Dermophisiologique S R L Soc Benefit Composizioni per il trattamento della dermatite atopica
WO2021074718A1 (pt) * 2019-10-16 2021-04-22 Tripod Maria Creme para tratamento de acne e melasma
IT202000004069A1 (it) * 2020-02-27 2021-08-27 Ricerfarma Srl Composizioni topiche per il mantenimento e/o ripristino dell’integrità delle mucose e dell’epidermide lesa

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360A (en) * 1985-04-09 1987-10-06 Societe Civile D'investigations Pharmacologiques D'aquitaine Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
JPH06336421A (ja) * 1993-05-28 1994-12-06 Kose Corp 皮膚外用剤
EP0694305A1 (en) * 1994-07-26 1996-01-31 INDENA S.p.A. Pharmaceutical or cosmetic formulations containing coumarins and proanthocyanidinis
DE10131641A1 (de) * 2000-12-22 2002-06-27 Schwabe Willmar Gmbh & Co Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel
EP1256335A1 (de) * 2001-05-10 2002-11-13 Cognis France S.A. Verwendung von oligomeren Procyanolidinen

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487774A (en) * 1892-12-13 Sectional steam-boiler
FR2509988B1 (fr) * 1981-07-23 1986-05-30 Oreal Melange d'huiles vegetales a base d'huile de jojoba comme agent de stabilisation a l'oxydation et compositions cosmetiques le contenant
IL64700A0 (en) * 1982-01-01 1982-03-31 Binderman Itzhak Dental care compositions
JPS60109519A (ja) 1983-11-17 1985-06-15 Nippon Shinyaku Co Ltd ニフェジピン坐剤
US5422118A (en) * 1986-11-07 1995-06-06 Pure Pac, Inc. Transdermal administration of amines with minimal irritation and high transdermal flux rate
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1215469B (it) 1987-05-08 1990-02-14 Yason Srl Composto ad attivita'mucoregolatrice e elastasi-inibitrice per la terapia dell'enfisema polmonare e della fibrosi polmonare.
JPH0725660B2 (ja) * 1990-05-29 1995-03-22 サンスター株式会社 日焼けに対する消炎性を有する化粧料
IT1254321B (it) * 1992-04-10 1995-09-14 Kemiprogress S R L Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
US5650432A (en) * 1995-03-24 1997-07-22 Jlb, Inc. Method of treating or preventing non-viral microbial infection
US5470874A (en) 1994-10-14 1995-11-28 Lerner; Sheldon Ascorbic acid and proanthocyanidine composition for topical application to human skin
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
US6471972B1 (en) * 1996-11-07 2002-10-29 Lvmh Recherche Cosmetic treatment method for fighting against skin ageing effects
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
WO1998052518A1 (en) * 1997-07-02 1998-11-26 Neutrogena Corporation Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof
EP0958833A1 (en) * 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Methods and means for preventing or treating inflammation
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
JP2000212057A (ja) * 1999-01-26 2000-08-02 Kansai Koso Kk 化粧料組成物
JP2001039844A (ja) * 1999-07-29 2001-02-13 Kikkoman Corp 咽喉用うがい剤
US6274124B1 (en) * 1999-08-20 2001-08-14 Dragoco Gerberding & Co. Ag Additive for improving the water resistance of cosmetic or dermatological formulations
JP2001081021A (ja) * 1999-09-09 2001-03-27 Ichimaru Pharcos Co Ltd 化粧料組成物
US6685970B1 (en) * 1999-09-21 2004-02-03 Kyowa Hakko Kogyo Co., Ltd. Compositions containing proanthocyanidin and a vitamin B6 derivative or a salt thereof
EP1226809B1 (en) * 1999-10-29 2007-05-30 Kyowa Hakko Kogyo Co., Ltd. Skin texture-improving agents
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360A (en) * 1985-04-09 1987-10-06 Societe Civile D'investigations Pharmacologiques D'aquitaine Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
JPH06336421A (ja) * 1993-05-28 1994-12-06 Kose Corp 皮膚外用剤
EP0694305A1 (en) * 1994-07-26 1996-01-31 INDENA S.p.A. Pharmaceutical or cosmetic formulations containing coumarins and proanthocyanidinis
DE10131641A1 (de) * 2000-12-22 2002-06-27 Schwabe Willmar Gmbh & Co Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel
EP1256335A1 (de) * 2001-05-10 2002-11-13 Cognis France S.A. Verwendung von oligomeren Procyanolidinen

Also Published As

Publication number Publication date
US7262180B2 (en) 2007-08-28
EP1494692A1 (en) 2005-01-12
GEP20074176B (en) 2007-08-10
TW200306849A (en) 2003-12-01
BRPI0309061B1 (pt) 2017-09-12
NO332753B1 (no) 2013-01-07
PT1494692E (pt) 2007-05-31
UA81408C2 (uk) 2008-01-10
US20050143324A1 (en) 2005-06-30
JP2005526822A (ja) 2005-09-08
HK1075617A1 (en) 2005-12-23
IL164434A0 (en) 2005-12-18
DE60313597T2 (de) 2007-09-06
IL164434A (en) 2009-09-22
PL204953B1 (pl) 2010-02-26
ITMI20020756A0 (it) 2002-04-09
PL371853A1 (en) 2005-06-27
CN1646151B (zh) 2010-05-05
JO2448B1 (en) 2008-10-09
KR20040104561A (ko) 2004-12-10
US20080114057A1 (en) 2008-05-15
RU2004129727A (ru) 2005-06-10
WO2003084553A1 (en) 2003-10-16
ITMI20020756A1 (it) 2003-10-09
AU2003226754B2 (en) 2007-08-16
AR039269A1 (es) 2005-02-16
CA2481770A1 (en) 2003-10-16
BR0309061A (pt) 2005-02-01
US20080015155A1 (en) 2008-01-17
MY137060A (en) 2008-12-31
NZ535813A (en) 2007-09-28
CY1106628T1 (el) 2012-01-25
ZA200408100B (en) 2006-07-26
TWI345979B (en) 2011-08-01
HRP20040917A2 (en) 2005-02-28
MXPA04009755A (es) 2004-12-13
DE60313597D1 (de) 2007-06-14
CA2481770C (en) 2011-10-04
NO20044259L (no) 2005-01-06
US20060247183A1 (en) 2006-11-02
RU2320362C2 (ru) 2008-03-27
AU2003226754A1 (en) 2003-10-20
DK1494692T3 (da) 2007-09-17
KR101065645B1 (ko) 2011-09-20
ES2285158T3 (es) 2007-11-16
ATE361084T1 (de) 2007-05-15
JP4861606B2 (ja) 2012-01-25
EP1494692B1 (en) 2007-05-02
CN1646151A (zh) 2005-07-27

Similar Documents

Publication Publication Date Title
HRP20040917B1 (hr) Topiäśki farmaceutski pripravci koji sadrže proantocijanide za tretman dermatitisa
BR0307564A (pt) Derivados de nicotinamida úteis como inibidores de pde4
SE0302923D0 (sv) Boswellin compositions enhanced with 3-beta-acetyl-11-keto- beta-boswellic acid (AKBA), industrial manufacture and their uses
WO2007014049A3 (en) Heparin compositions and selectin inhibition
EA200800664A1 (ru) Производные пирролопиримидина в качестве ингибиторов syk
WO2008005303A3 (en) Thiazolopyrimidine modulators of trpv1
WO2008097824A3 (en) Use of arsenic compounds for treatment of pain and inflammation
ECSP088923A (es) Compuestos de triazolopirazina utiles para el tratamiento de enfermedades degenerativas e inflamatorias
EA200400595A1 (ru) Бензимидазолы, применяемые в качестве ингибиторов протеинкиназы
WO2008083228A3 (en) Compositions and methods for treating inflammation and auto-immune diseases
YU46701A (sh) Antiinflamatorna i imunosupresivna jedinjenja podobna za inhibiciju ćelijske adhezije
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
BRPI0408388A (pt) compostos de benzopirano úteis no tratamento de patologias inflamatórias
MX2007011493A (es) Modalidades antiinflamatorias.
TW200942549A (en) Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
ATE414526T1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
AR038628A1 (es) Composicion oftalmica
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
ECSP034470A (es) 6.alfa.,9.alfa-difluor-17.alfa.- (2-furanilcarboxilo) oxy-11.beta.-hidroxi-16.alfa.-metil-3-oxo-androst-1,4,-diene-17-acido carbotiotico s-fluormetil ester como un agente anti-inflamatorio
EA200700044A1 (ru) Композиция для местного применения
TR200103004T2 (tr) Pirolidinkarbonilamino siklik disülfitler.
BRPI0514600A (pt) métodos para a fabricação de um composto, para a purificação de um composto, para o tratamento de um indivìduo tendo uma condição neoplástica, tendo carcinoma de célula escamosa, e tendo carcinoma de célula basal, para a redução ou prevenção da ocorrência de uma condição neoplástica em um indivìduo, e para a redução de triglicerìdeos no soro em um indivìduo, composto, e, composição farmacêutica
BRPI0508927A (pt) compostos úteis para o tratamento de doenças
DE602004031964D1 (de) Ndlung von dermatologischen erkrankungen
SE9901345L (sv) CMOS process

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: SINCLAIR PHARMACEUTICALS LIMITED, GB

PPPP Transfer of rights

Owner name: MAELOR LABORATORIES LIMITED, GB

ODRP Renewal fee for the maintenance of a patent

Payment date: 20190115

Year of fee payment: 17

PBON Lapse due to non-payment of renewal fee

Effective date: 20200331